Related Experiment Video

Updated: Jun 26, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression

C Andrew Stewart1, Giorgio Trinchieri

  • 1Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.

Cancer Cell
|February 3, 2009
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) promotes tumor growth by increasing protumor IL-23 in macrophages and decreasing antitumor IL-12 in dendritic cells within the tumor microenvironment. STAT3 further activates tumor-infiltrating regulatory T cells via IL-23.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor involved in various cellular processes, including tumorigenesis.
  • The tumor microenvironment (TME) comprises complex interactions between tumor cells and immune cells, significantly influencing cancer progression.
  • Cytokines like Interleukin-23 (IL-23) and Interleukin-12 (IL-12) play critical roles in modulating immune responses within the TME.

Purpose of the Study:

  • To investigate the specific roles of STAT3 in regulating immune cell function and cytokine expression within the tumor microenvironment.
  • To elucidate how STAT3 influences the balance between protumor and antitumor immune responses.
  • To understand the mechanisms by which STAT3 affects regulatory T cell activation in the context of cancer.

Main Methods:

  • The study likely involved experiments analyzing STAT3 expression and activity in immune cells within the TME.
  • Methods may include cytokine profiling (IL-23, IL-12) in macrophages and dendritic cells.
  • Techniques to assess regulatory T cell activation and function in response to STAT3-mediated signaling were probably employed.

Main Results:

  • STAT3 was found to enhance the expression of the protumor cytokine IL-23 in macrophages.
  • Conversely, STAT3 was shown to inhibit the expression of the antitumor cytokine IL-12 in dendritic cells.
  • STAT3 was demonstrated to mediate the activation of tumor-infiltrating regulatory T cells, driven by IL-23.

Conclusions:

  • STAT3 acts as a critical regulator of immune cell function in the TME, promoting a protumorigenic environment.
  • By differentially regulating IL-23 and IL-12, STAT3 skews the immune response towards tumor progression.
  • Targeting STAT3 signaling may represent a therapeutic strategy to rebalance immune responses against cancer.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...